tamibarotene

US Patent and Trademark Office Issued a License for Cytrx Corporation's Patent Application
Jul 10, 2012
The US Patent and Trademark Office (USPTO) has issued a notice of allowance for CytRx Corporation's patent application covering a pharmaceutical composition of tamibarotene in capsule form. Tamibarotene is an orally available, ...

Tags: notice of allowance, patent application, tamibarotene, USPTO